European Commission approves low-dose atropine eye drop Ryjunea, Santen announces

Published on June 5, 2025
The 0.1 mg/ml atropine eye drop for paediatric myopia is licensed from Sydnexis, Inc.
Continue reading on website
Other news

Atropine vs spectacles: Which move will be more powerful in the game of myopia management?

June 5, 2025
An official approval by the FDA in the United States can boost adoption rate of atropine and antimyopia glasses, which will change the landscape of myopia management.

New York Eye and Ear Infirmary of Mount Sinai Opens Comprehensive Center for Refractive Solutions in New York City

June 6, 2025
NEW YORK—New York Eye and Ear Infirmary of Mount Sinai (NYEE) has announced the opening of the Center for Refractive Solutions—the first in New York City and one of few in the United States—that offers comprehensive and innovative treatment options for those who require refractive correction. This includes premium cataract and intraocular lens surgery, and corneal refractive procedures such as LAS